Novel source of human hematopoietic stem cells from peritoneal dialysis effluents

Jinhui Shen; Junke Zheng; Ramesh Saxena; Chengcheng Zhang; Liping Tang

doi:10.1016/j.scr.2015.07.003

Novel source of human hematopoietic stem cells from peritoneal dialysis effluents

Jinhui Shen, Junke Zheng, Ramesh Saxena, Chengcheng Zhang, Liping Tang

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Hematopoietic stem cells (HSCs) hold great promise for the treatment of various diseases and blood disorders. However, limited availability of these cells has hampered their applications in clinical and biological research. Here we have identified a new source of autologous human HSCs in peritoneal dialysis (PD) effluents from patients with end stage renal diseases (ESRDs). Cells isolated from PD effluents contain a Lin^-/CD34⁺/CD38^-/CD90⁺ sub-population and can repopulate NOD/SCID/gamma-/- mice in serial transplantation. Differing from cord blood HSCs, PD-derived HSCs have high tendencies to repopulate peritoneal cavity and spleen with myeloid cells and B lymphocytes. Repopulating HSCs also reside in peritoneal cavities in mice. The isolation of HSCs from peritoneal cavities provides a novel and promising source of autologous and functional HSCs for stem cell research and possible clinical use.

Original language	English (US)
Pages (from-to)	299-304
Number of pages	6
Journal	Stem Cell Research
Volume	15
Issue number	2
DOIs	https://doi.org/10.1016/j.scr.2015.07.003
State	Published - Sep 1 2015

Keywords

Hematopoietic stem cells
Peritoneal dialysis

ASJC Scopus subject areas

Developmental Biology
Cell Biology

Access to Document

10.1016/j.scr.2015.07.003

Cite this

@article{6b87e439fa754784a4fcbb6de36455b6,

title = "Novel source of human hematopoietic stem cells from peritoneal dialysis effluents",

abstract = "Hematopoietic stem cells (HSCs) hold great promise for the treatment of various diseases and blood disorders. However, limited availability of these cells has hampered their applications in clinical and biological research. Here we have identified a new source of autologous human HSCs in peritoneal dialysis (PD) effluents from patients with end stage renal diseases (ESRDs). Cells isolated from PD effluents contain a Lin-/CD34+/CD38-/CD90+ sub-population and can repopulate NOD/SCID/gamma-/- mice in serial transplantation. Differing from cord blood HSCs, PD-derived HSCs have high tendencies to repopulate peritoneal cavity and spleen with myeloid cells and B lymphocytes. Repopulating HSCs also reside in peritoneal cavities in mice. The isolation of HSCs from peritoneal cavities provides a novel and promising source of autologous and functional HSCs for stem cell research and possible clinical use.",

keywords = "Hematopoietic stem cells, Peritoneal dialysis",

author = "Jinhui Shen and Junke Zheng and Ramesh Saxena and Chengcheng Zhang and Liping Tang",

note = "Publisher Copyright: {\textcopyright} 2015.",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.scr.2015.07.003",

language = "English (US)",

volume = "15",

pages = "299--304",

journal = "Stem Cell Research",

issn = "1873-5061",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Novel source of human hematopoietic stem cells from peritoneal dialysis effluents

AU - Shen, Jinhui

AU - Zheng, Junke

AU - Saxena, Ramesh

AU - Zhang, Chengcheng

AU - Tang, Liping

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Hematopoietic stem cells (HSCs) hold great promise for the treatment of various diseases and blood disorders. However, limited availability of these cells has hampered their applications in clinical and biological research. Here we have identified a new source of autologous human HSCs in peritoneal dialysis (PD) effluents from patients with end stage renal diseases (ESRDs). Cells isolated from PD effluents contain a Lin-/CD34+/CD38-/CD90+ sub-population and can repopulate NOD/SCID/gamma-/- mice in serial transplantation. Differing from cord blood HSCs, PD-derived HSCs have high tendencies to repopulate peritoneal cavity and spleen with myeloid cells and B lymphocytes. Repopulating HSCs also reside in peritoneal cavities in mice. The isolation of HSCs from peritoneal cavities provides a novel and promising source of autologous and functional HSCs for stem cell research and possible clinical use.

AB - Hematopoietic stem cells (HSCs) hold great promise for the treatment of various diseases and blood disorders. However, limited availability of these cells has hampered their applications in clinical and biological research. Here we have identified a new source of autologous human HSCs in peritoneal dialysis (PD) effluents from patients with end stage renal diseases (ESRDs). Cells isolated from PD effluents contain a Lin-/CD34+/CD38-/CD90+ sub-population and can repopulate NOD/SCID/gamma-/- mice in serial transplantation. Differing from cord blood HSCs, PD-derived HSCs have high tendencies to repopulate peritoneal cavity and spleen with myeloid cells and B lymphocytes. Repopulating HSCs also reside in peritoneal cavities in mice. The isolation of HSCs from peritoneal cavities provides a novel and promising source of autologous and functional HSCs for stem cell research and possible clinical use.

KW - Hematopoietic stem cells

KW - Peritoneal dialysis

UR - http://www.scopus.com/inward/record.url?scp=84937786326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937786326&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2015.07.003

DO - 10.1016/j.scr.2015.07.003

M3 - Article

C2 - 26209817

AN - SCOPUS:84937786326

SN - 1873-5061

VL - 15

SP - 299

EP - 304

JO - Stem Cell Research

JF - Stem Cell Research

IS - 2

ER -

Novel source of human hematopoietic stem cells from peritoneal dialysis effluents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this